Streetbeat News

LIFW

MSP Recovery, Inc.

https://www.msprecovery.com

Industry

Medical - Healthcare Information Services

MSP Recovery, Inc. operates as a healthcare recoveries and data analytics company in the United States and Puerto Rico. The company offers claims recovery services, including services to related parties or third parties to assist entities with pursuit of claims recovery rights. It also provides Chase to pay service to assist its healthcare provider clients to identify in the first instance the proper primary insurer at the point of care and thereby avoid making a wrongful payment; and LifeWallet, a platform designed to locate and organize users' medical records. MSP Recovery, Inc. was founded in 2014 and is headquartered in Coral Gables, Florida.

Open

0.12

Mkt cap

19M

Volume

3.3M

High

0.12

P/E Ratio

-0.02

52-wk high

8.25

Low

0.10

Div yield

N/A

52-wk low

0.09

MSP Recovery (NASDAQ:LIFW) reported a significant improvement in its Q1 financial results, with a 75.11% reduction in EPS losses and a 50.21% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 7:08 am

In Thursday's after-market session, health care stocks saw significant movements. Tevogen Bio Holdings led the gainers with a 51.8% increase, while Vincerx Pharma experienced the largest drop among the losers, declining by 17.5%. ResMed and DexCom reported their Q3 and Q1 earnings, respectively, influencing their stock prices.

Portfolio Pulse from Benzinga Insights

April 25, 2024 | 8:32 pm

In Monday's intraday session, several healthcare stocks experienced significant movements. NKGen Biotech led the gainers with a 33.8% increase, while Vaxxinity saw the largest decline among the losers, dropping 52.9%. Other notable movers included MSP Recovery, Assure Holdings, ProKidney, iSpecimen, GlucoTrack, Hepion Pharmaceuticals, Bio-Path Holdings, Inhibikase Therapeutics, Telomir Pharmaceuticals, and Ocean Biomedical. Market capitalizations varied widely among these companies, reflecting diverse investor reactions to recent earnings reports and market dynamics.

Portfolio Pulse from Benzinga Insights

April 22, 2024 | 4:31 pm

In Friday's pre-market session, several healthcare stocks showed significant movement. Chromocell Therapeutics, Kineta, Portage Biotech, Erasca, MSP Recovery, and Cue Health were among the gainers, with increases ranging from 12.25% to 21.6%. On the downside, Nexalin Technology, iSpecimen, INVO Bioscience, Intelligent Bio Solutions, Trevena, and PaxMedica experienced declines between 9.58% and 18.4%. Notably, MSP Recovery and INVO Bioscience had recent earnings reports influencing their stock movements.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 12:08 pm

MSP Recovery's stock is trading higher following the announcement of a settlement with 10 affiliated property and casualty insurers operating in 15 states.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 11:55 am

LifeWallet has reached a settlement with 10 affiliated property and casualty insurers, expanding its claims processing capabilities across 15 states. This agreement marks a significant step in LifeWallet's growth and expansion strategy, potentially increasing its market share and operational efficiency in the insurance sector.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 6:44 am

In Monday's intraday session, several healthcare stocks experienced significant movements. Longeveron, Mobile-health Network, Jaguar Health, Soligenix, ProKidney, and Organovo Holdings were among the gainers, with increases ranging from 24.58% to 44.4%. Conversely, Marinus Pharma, Alterity Therapeutics, BioSig Technologies, Rallybio, MSP Recovery, and China SXT Pharmaceuticals faced declines, with Marinus Pharma dropping by 79.8%. The movements reflect varying market capitalizations and investor reactions to company-specific news, including MSP Recovery's Q4 earnings report.

Portfolio Pulse from Benzinga Insights

April 15, 2024 | 4:31 pm

MSP Recovery shares are trading lower following a report of decreased year-over-year sales results.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 3:17 pm

MSP Recovery reported a fiscal year adjusted EPS loss of $73.3 million, an increase from last year's $44.8 million loss. Sales decreased to $7.71 million from $23.42 million year-over-year.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:13 am

In Thursday's intraday session, several healthcare stocks experienced significant movements. Rallybio, Eliem Therapeutics, and Candel Therapeutics were among the top gainers, with shares increasing by 70.5%, 57.3%, and 40.58% respectively. Conversely, Aptevo Therapeutics, AVITA Medical, and BioSig Technologies were the leading losers, with their shares falling by 57.9%, 30.61%, and 25.35% respectively. These movements reflect notable volatility within the healthcare sector.

Portfolio Pulse from Benzinga Insights

April 11, 2024 | 4:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.